Stocks · Health care · Pharmaceutical Preparations

PRECIGEN, INC.

PGEN Clue Score19
United States Fiscal year ends December CIK 0001356090 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

13 insiders · 0 transactions
28.1×

Helen Sabzevari holds 28.1 times base salary in stock. $28.12M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Helen Sabzevari last reported holding, valued at $7.44, the price Common Stock was last bought or sold at on the open market here, on 26 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Randal J Kirk
Director
—
—
—
12,262,741
$91.23M
+12.3%
Helen Sabzevari
President and CEO
—
—
—
3,779,521
$28.12M
+70.2%
Fred Hassan
Director
—
—
—
1,243,239
$9.25M
+20.7%
Steven Frank
Director
—
—
—
1,226,391
$9.12M
+19.7%
Cesar L Alvarez
Director
—
—
—
782,909
$5.82M
+37.4%
Donald P. Lehr
Chief Legal Officer
—
—
—
758,181
$5.64M
+40.9%
James S Turley
Director
—
—
—
685,417
$5.10M
+45.1%
Vinita D Gupta
Director
—
—
—
666,027
$4.96M
+47.1%
Rutul R Shah
Chief Operating Officer
—
—
—
468,865
$3.49M
+123.5%
Harry Thomasian Jr.
Chief Financial Officer
—
—
—
311,914
$2.32M
+36.0%
Nancy H Agee
Director
—
—
—
309,187
$2.30M
+1,656%
Phil Tennant
Chief Commercial Officer
—
—
—
141,992
$1.06M
—
Jeffrey B Kindler
Director
—
—
—
17,100
$127.22K
−95.7%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.